Review



il-17a il-17f neutralizing antibodies  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Bio X Cell il-17a il-17f neutralizing antibodies
    KEY RESOURCES TABLE
    Il 17a Il 17f Neutralizing Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il-17a+il-17f+neutralizing+antibodies/anti+il+17a+17f3/pmc07181337-721-8-18
    Average 90 stars, based on 1 article reviews
    il-17a il-17f neutralizing antibodies - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer"

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer

    Journal: Cancer cell

    doi: 10.1016/j.ccell.2020.02.008

    KEY RESOURCES TABLE
    Figure Legend Snippet: KEY RESOURCES TABLE

    Techniques Used: Recombinant, Cell Stimulation, Enzyme-linked Immunosorbent Assay, CyQUANT Assay, LDH Cytotoxicity Assay, Expressing, Staining, Derivative Assay, Software

    Related Articles

    Recombinant:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Cell Stimulation:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    CyQUANT Assay:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    LDH Cytotoxicity Assay:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Expressing:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Staining:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Derivative Assay:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Software:

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.



    Similar Products

    il-17a il-17f neutralizing antibodies  (Bio X Cell)
    90
    Bio X Cell il-17a il-17f neutralizing antibodies
    KEY RESOURCES TABLE
    Il 17a Il 17f Neutralizing Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il-17a+il-17f+neutralizing+antibodies/anti+il+17a+17f3/pmc07181337-721-8-18
    Average 90 stars, based on 1 article reviews
    il-17a il-17f neutralizing antibodies - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    monoclonal neutralizing antibodies against il-17 signaling (il-17ra, il-17a and il-17f)  (Amgen)
    90
    Amgen monoclonal neutralizing antibodies against il-17 signaling (il-17ra, il-17a and il-17f)
    KEY RESOURCES TABLE
    Monoclonal Neutralizing Antibodies Against Il 17 Signaling (Il 17ra, Il 17a And Il 17f), supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il-17a+il-17f+neutralizing+antibodies/il17ra+++++mice/pmc06035075-124-1-16
    Average 90 stars, based on 1 article reviews
    monoclonal neutralizing antibodies against il-17 signaling (il-17ra, il-17a and il-17f) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    neutralizing antibodies against il-17a, il-17f, and il-23  (Centocor Inc)
    90
    Centocor Inc neutralizing antibodies against il-17a, il-17f, and il-23
    KEY RESOURCES TABLE
    Neutralizing Antibodies Against Il 17a, Il 17f, And Il 23, supplied by Centocor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/il-17a+il-17f+neutralizing+antibodies/anti+il+17a+antibody/pm20148686-411-35-21
    Average 90 stars, based on 1 article reviews
    neutralizing antibodies against il-17a, il-17f, and il-23 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    KEY RESOURCES TABLE

    Journal: Cancer cell

    Article Title: Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer

    doi: 10.1016/j.ccell.2020.02.008

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: For cytokine depletion regimen, 400 μg each of IL-17A and IL-17F neutralizing antibodies (rat clone 17F3; clone MM17F8F5.1A9, BioXCell) or 250 μg of IFN-γ neutralizing antibodies (rat clone XMG1.2, BioXCell) were similarly administered (every 3-4 days) until 6-week timepoint was reached.

    Techniques: Recombinant, Cell Stimulation, Enzyme-linked Immunosorbent Assay, CyQUANT Assay, LDH Cytotoxicity Assay, Expressing, Staining, Derivative Assay, Software